Display options
Share it on

Pediatr Allergy Immunol Pulmonol. 2012 Mar;25(1):11-16. doi: 10.1089/ped.2011.0118.

Availability of Asthma Quick Relief Medication in Five Alabama School Systems.

Pediatric allergy, immunology, and pulmonology

Joe K Gerald, Nancy Stroupe, Leslie A McClure, Lani Wheeler, Lynn B Gerald

PMID: 22454787 PMCID: PMC3306583 DOI: 10.1089/ped.2011.0118

Abstract

OBJECTIVES: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. PATIENTS AND METHODS: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. RESULTS: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. CONCLUSION: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.

References

  1. J Sch Health. 2006 Jan;76(1):18-24 - PubMed
  2. Arch Pediatr Adolesc Med. 2000 Jul;154(7):685-93 - PubMed
  3. J Asthma. 2005 Feb;42(1):51-3 - PubMed
  4. J Pediatr. 1996 Nov;129(5):735-42 - PubMed
  5. J Sch Health. 2006 Aug;76(6):329-32 - PubMed
  6. J Sch Nurs. 2007 Jun;23(3):170-6 - PubMed
  7. Prev Chronic Dis. 2005 Jan;2(1):A11 - PubMed
  8. J Asthma. 2000 Dec;37(8):719-24 - PubMed
  9. J Sch Nurs. 2009 Oct;25(5):382-94 - PubMed
  10. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138 - PubMed
  11. Pediatrics. 2009 Feb;123(2):466-74 - PubMed
  12. J Sch Health. 2006 Aug;76(6):325-8 - PubMed
  13. Pediatrics. 2006 Sep;118(3):1097-103 - PubMed
  14. Pediatrics. 2005 Dec;116(6):e738-45 - PubMed
  15. J Sch Nurs. 2003 Jun;19(3):150-6 - PubMed
  16. Adv Data. 2006 Dec 12;(381):1-24 - PubMed
  17. Chest. 2009 Feb;135(2):303-306 - PubMed
  18. Pediatrics. 2004 Oct;114(4):e459-68 - PubMed
  19. Pediatr Clin North Am. 2003 Jun;50(3):655-75, vii - PubMed
  20. J Sch Nurs. 2005 Feb;21(1):23-30 - PubMed
  21. Vital Health Stat 10. 2009 Dec;(244):1-81 - PubMed
  22. J Asthma. 2009 May;46(4):392-8 - PubMed
  23. J Sch Health. 1999 Aug;69(6):233-8 - PubMed
  24. J Sch Nurs. 2002 Jun;18(3):128-37 - PubMed
  25. Contemp Clin Trials. 2008 Mar;29(2):304-10 - PubMed
  26. J Pediatr. 2001 Jan;138(1):59-64 - PubMed
  27. Am J Respir Crit Care Med. 2004 Apr 1;169(7):873-81 - PubMed
  28. J Sch Nurs. 2006 Dec;22(6):319-29 - PubMed
  29. J Allergy Clin Immunol. 2006 Dec;118(6):1226-33 - PubMed
  30. J Sch Health. 2006 Aug;76(6):336-9 - PubMed

Publication Types